Institutional Manager · CIK 0001053906
Artal Group S.A.
LUXEMBOURG, N4 · File #028-15027
Latest AUM
$714.6M
Positions
2
Top-10 Concentration
100.0%
Filings
10
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| REDUCE | Cava Group Inc | CAVA | 0 | $0 | -$16.4M |
| REDUCE | Lexicon Pharmaceuticals Inc | LXRX | 0 | $0 | -$27.2M |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 20252 pos · $714.6M
- 13F HOLDINGS REPORTQ/E Sep 20252 pos · $758.2M
- 13F HOLDINGS REPORTQ/E Jun 20252 pos · $930.2M
- 13F HOLDINGS REPORTQ/E Mar 20252 pos · $884.2M
- 13F HOLDINGS REPORTQ/E Dec 20242 pos · $1.17B
- 13F HOLDINGS REPORTQ/E Sep 20242 pos · $2.38B
- 13F HOLDINGS REPORTQ/E Jun 2024114 pos · $3.92B
- 13F HOLDINGS REPORT (Amended)Q/E Mar 2024113 pos · $3.93B
- 13F HOLDINGS REPORTQ/E Mar 2024112 pos · $3.92B
- 13F HOLDINGS REPORTQ/E Dec 2023105 pos · $2.3M
Top 2 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | Cava Group Inc | CAVA | 9,507,990 | $558.0M | 78.09% |
| 2 | Lexicon Pharmaceuticals Inc | LXRX | 136,180,481 | $156.6M | 21.91% |